Duke Clinical Research Institute
- Advisory Board: Eli Lilly and Company; Pfizer Inc.; Shire Pharmaceuticals Inc.
- Consultant: Atentiv; Bristol-Myers Squibb; DLA Piper; Eli Lilly and Company; Pfizer Inc.; Widay
- Data Safety Monitoring Board: Eli Lilly and Company; Pfizer Inc.
- Research Support: Pfizer Inc.
- Royalties: Guilford Press; Multi-Health Systems; Oxford University Press
- Stock or Equity: MedAvante